Jeremy Grantham Emergent Bio Solutions Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $6.27 Million - $10.3 Million	-76,500 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$54.33 - $89.52 $1.97 Million - $3.25 Million	36,300 Added 90.3%	76,500 $6.05 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $1.98 Million - $2.76 Million	40,200 New	40,200 $2.33 Million
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $475,048 - $640,934	-11,900 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$55.63 - $73.24 $211,394 - $278,312	-3,800 Reduced 24.2%	11,900 $705,000
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $1.16 Million - $1.48 Million	-22,296 Reduced 58.68%	15,700 $1.03 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $1.09 Million - $1.26 Million	22,596 Added 146.73%	37,996 $1.92 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $581,658 - $735,350	15,400	15,400 $716,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $500M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.